• Study on the Safety and Tolerability of Rugonersen in Patients with Angelman Syndrome

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy The Netherlands Spain

  • Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Greece Italy The Netherlands

  • Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy

  • Study on the Effectiveness of Tislelizumab and Spartalizumab in Patients with Advanced or Metastatic Cancer with High PD1 Biomarker Levels

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Gabapentin and Placebo for Short-Term Relief of Acute Lower Back Pain from Herniated Disc in Adults

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Lithuania The Netherlands Norway Sweden

  • Study on Celecoxib for Reducing Symptoms in Adults with Major Depressive Disorder and Immuno-metabolic Characteristics

    Not recruiting

    3 1 1
    Investigated drugs:
    The Netherlands

  • Study on Organ Preservation in Advanced Rectal Cancer Using Oxaliplatin, Fluorouracil, and Calcium Folinate for Patients with Confirmed Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Bexmarilimab Combined with Standard Treatment for Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated drugs:
    Finland

powered by